Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Madrigal Pharmaceuticals, Inc."
Count: 15
Selected: 0
NCT IDTitle
NCT04951219A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)
NCT03900429A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis
NCT04643795Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control Subjects
NCT04197479A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients
NCT01367873Ascending Single-Dose Study to Evaluate VIA-3196 in Healthy Subjects
NCT05500222A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)
NCT02542969Drug Interaction Study of MGL-3196 With Rosuvastatin and Simvastatin
NCT04671069Drug Interaction Study of MGL-3196 With Clopidogrel
NCT04671056Drug Interaction Study of MGL-3196 With Pioglitazone
NCT03413124Bioavailability Study of MGL-3196 Tablets Compared to Capsules
NCT03038022Study of MGL-3196 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
NCT03220165Radiolabeled Study to Determine the Mass Balance of [14C] MGL-3196
NCT02912260Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)
NCT02749578Drug Interaction Study of MGL-3196 With Atorvastatin
NCT01519531Ascending Multiple-Dose Study to Evaluate VIA-3196 in Healthy Subjects